<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-07-19" modified="2017-12-20" version="134">
<accession>Q6VVB1</accession>
<accession>Q3SYB1</accession>
<accession>Q5VUK7</accession>
<accession>Q6IMH1</accession>
<name>NHLC1_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase NHLRC1</fullName>
<ecNumber>2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Malin</fullName>
</alternativeName>
<alternativeName>
<fullName>NHL repeat-containing protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="14">RING-type E3 ubiquitin transferase NHLRC1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NHLRC1</name>
<name type="synonym">EPM2B</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2003" name="Nat. Genet." volume="35" first="125" last="127">
<title>Mutations in NHLRC1 cause progressive myoclonus epilepsy.</title>
<authorList>
<person name="Chan E.M."/>
<person name="Young E.J."/>
<person name="Ianzano L."/>
<person name="Munteanu I."/>
<person name="Zhao X."/>
<person name="Christopoulos C.C."/>
<person name="Avanzini G."/>
<person name="Elia M."/>
<person name="Ackerley C.A."/>
<person name="Jovic N.J."/>
<person name="Bohlega S."/>
<person name="Andermann E."/>
<person name="Rouleau G.A."/>
<person name="Delgado-Escueta A.V."/>
<person name="Minassian B.A."/>
<person name="Scherer S.W."/>
</authorList>
<dbReference type="PubMed" id="12958597"/>
<dbReference type="DOI" id="10.1038/ng1238"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS EPM2 SER-26; SER-33; ALA-69; PRO-87; ASN-146 AND PRO-302</scope>
<scope>VARIANT LEU-111</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2003" name="Nature" volume="425" first="805" last="811">
<title>The DNA sequence and analysis of human chromosome 6.</title>
<authorList>
<person name="Mungall A.J."/>
<person name="Palmer S.A."/>
<person name="Sims S.K."/>
<person name="Edwards C.A."/>
<person name="Ashurst J.L."/>
<person name="Wilming L."/>
<person name="Jones M.C."/>
<person name="Horton R."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Gilbert J.G.R."/>
<person name="Clamp M.E."/>
<person name="Bethel G."/>
<person name="Milne S."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews T.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bray-Allen S."/>
<person name="Brook J."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clark G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Collins J.E."/>
<person name="Colman L.K."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Culley K.M."/>
<person name="Dhami P."/>
<person name="Davies J."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.E."/>
<person name="Evans K.A."/>
<person name="Faulkner L."/>
<person name="Francis M.D."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori M.J."/>
<person name="Gilby L.M."/>
<person name="Gillson C.J."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Grant M."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Hall R."/>
<person name="Halls K.S."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Heathcott R."/>
<person name="Holmes S.J."/>
<person name="Howden P.J."/>
<person name="Howe K.L."/>
<person name="Howell G.R."/>
<person name="Huckle E."/>
<person name="Humphray S.J."/>
<person name="Humphries M.D."/>
<person name="Hunt A.R."/>
<person name="Johnson C.M."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S.J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C.R."/>
<person name="Lloyd D.M."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Maslen G.L."/>
<person name="Matthews L."/>
<person name="McCann O.T."/>
<person name="McLaren S.J."/>
<person name="McLay K."/>
<person name="McMurray A."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Niblett D."/>
<person name="Nickerson T."/>
<person name="Novik K.L."/>
<person name="Oliver K."/>
<person name="Overton-Larty E.K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S."/>
<person name="Plumb R.W."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Ranby S.A."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Searle S.M."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Skuce C.D."/>
<person name="Smith S."/>
<person name="Smith M."/>
<person name="Spraggon L."/>
<person name="Squares S.L."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tamlyn-Hall G."/>
<person name="Tester J."/>
<person name="Theaker A.J."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="White S.S."/>
<person name="Whitehead S.L."/>
<person name="Whittaker H."/>
<person name="Wild A."/>
<person name="Willey D.J."/>
<person name="Wilmer T.E."/>
<person name="Wood J.M."/>
<person name="Wray P.W."/>
<person name="Wyatt J.C."/>
<person name="Young L."/>
<person name="Younger R.M."/>
<person name="Bentley D.R."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Dunham I."/>
<person name="Rogers J."/>
<person name="Beck S."/>
</authorList>
<dbReference type="PubMed" id="14574404"/>
<dbReference type="DOI" id="10.1038/nature02055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT LEU-111</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="8501" last="8506">
<title>Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.</title>
<authorList>
<person name="Gentry M.S."/>
<person name="Worby C.A."/>
<person name="Dixon J.E."/>
</authorList>
<dbReference type="PubMed" id="15930137"/>
<dbReference type="DOI" id="10.1073/pnas.0503285102"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EPM2A</scope>
<scope>DOMAIN RING</scope>
<scope>CHARACTERIZATION OF VARIANT EPM2 PRO-302</scope>
<scope>MUTAGENESIS OF GLU-280</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="Genes Dev." volume="21" first="2399" last="2409">
<title>A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease.</title>
<authorList>
<person name="Cheng A."/>
<person name="Zhang M."/>
<person name="Gentry M.S."/>
<person name="Worby C.A."/>
<person name="Dixon J.E."/>
<person name="Saltiel A.R."/>
</authorList>
<dbReference type="PubMed" id="17908927"/>
<dbReference type="DOI" id="10.1101/gad.1553207"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH AGL</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="4069" last="4076">
<title>Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG).</title>
<authorList>
<person name="Worby C.A."/>
<person name="Gentry M.S."/>
<person name="Dixon J.E."/>
</authorList>
<dbReference type="PubMed" id="18070875"/>
<dbReference type="DOI" id="10.1074/jbc.M708712200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2009" name="Hum. Mol. Genet." volume="18" first="688" last="700">
<title>The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system.</title>
<authorList>
<person name="Garyali P."/>
<person name="Siwach P."/>
<person name="Singh P.K."/>
<person name="Puri R."/>
<person name="Mittal S."/>
<person name="Sengupta S."/>
<person name="Parihar R."/>
<person name="Ganesh S."/>
</authorList>
<dbReference type="PubMed" id="19036738"/>
<dbReference type="DOI" id="10.1093/hmg/ddn398"/>
</citation>
<scope>FUNCTION</scope>
<scope>COMPLEX FORMATION WITH EPM2A AND HSP70</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2012" name="Brain" volume="135" first="2684" last="2698">
<title>Early-onset Lafora body disease.</title>
<authorList>
<person name="Turnbull J."/>
<person name="Girard J.M."/>
<person name="Lohi H."/>
<person name="Chan E.M."/>
<person name="Wang P."/>
<person name="Tiberia E."/>
<person name="Omer S."/>
<person name="Ahmed M."/>
<person name="Bennett C."/>
<person name="Chakrabarty A."/>
<person name="Tyagi A."/>
<person name="Liu Y."/>
<person name="Pencea N."/>
<person name="Zhao X."/>
<person name="Scherer S.W."/>
<person name="Ackerley C.A."/>
<person name="Minassian B.A."/>
</authorList>
<dbReference type="PubMed" id="22961547"/>
<dbReference type="DOI" id="10.1093/brain/aws205"/>
</citation>
<scope>INTERACTION WITH PRDM8</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2013" name="Int. J. Biochem. Cell Biol." volume="45" first="1479" last="1488">
<title>Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is modulated by the laforin-malin complex.</title>
<authorList>
<person name="Rubio-Villena C."/>
<person name="Garcia-Gimeno M.A."/>
<person name="Sanz P."/>
</authorList>
<dbReference type="PubMed" id="23624058"/>
<dbReference type="DOI" id="10.1016/j.biocel.2013.04.019"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="J. Hum. Genet." volume="50" first="347" last="352">
<title>Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population.</title>
<authorList>
<person name="Singh S."/>
<person name="Suzuki T."/>
<person name="Uchiyama A."/>
<person name="Kumada S."/>
<person name="Moriyama N."/>
<person name="Hirose S."/>
<person name="Takahashi Y."/>
<person name="Sugie H."/>
<person name="Mizoguchi K."/>
<person name="Inoue Y."/>
<person name="Kimura K."/>
<person name="Sawaishi Y."/>
<person name="Yamakawa K."/>
<person name="Ganesh S."/>
</authorList>
<dbReference type="PubMed" id="16021330"/>
<dbReference type="DOI" id="10.1007/s10038-005-0263-7"/>
</citation>
<scope>VARIANTS EPM2 MET-153; ARG-160; ARG-219; ASN-245 AND LYS-253</scope>
<scope>VARIANT LEU-111</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Neurology" volume="64" first="982" last="986">
<title>Lafora disease due to EPM2B mutations: a clinical and genetic study.</title>
<authorList>
<person name="Gomez-Abad C."/>
<person name="Gomez-Garre P."/>
<person name="Gutierrez-Delicado E."/>
<person name="Saygi S."/>
<person name="Michelucci R."/>
<person name="Tassinari C.A."/>
<person name="Rodriguez de Cordoba S."/>
<person name="Serratosa J.M."/>
</authorList>
<dbReference type="PubMed" id="15781812"/>
<dbReference type="DOI" id="10.1212/01.WNL.0000154519.10805.F7"/>
</citation>
<scope>VARIANTS EPM2 GLN-67; TYR-68; ASN-198; ALA-233; HIS-264; 294-VAL-LYS-295 DEL AND ALA-308</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Hum. Mutat." volume="29" first="E1" last="12">
<title>Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin.</title>
<authorList>
<person name="Singh S."/>
<person name="Satishchandra P."/>
<person name="Shankar S.K."/>
<person name="Ganesh S."/>
</authorList>
<dbReference type="PubMed" id="18311786"/>
<dbReference type="DOI" id="10.1002/humu.20737"/>
</citation>
<scope>VARIANTS EPM2 ARG-22; PRO-126 AND PRO-279</scope>
<scope>CHARACTERIZATION OF VARIANTS EPM2 ARG-22; PRO-126 AND PRO-279</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2011" name="J. Mol. Med." volume="89" first="915" last="925">
<title>Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism.</title>
<authorList>
<person name="Couarch P."/>
<person name="Vernia S."/>
<person name="Gourfinkel-An I."/>
<person name="Lesca G."/>
<person name="Gataullina S."/>
<person name="Fedirko E."/>
<person name="Trouillard O."/>
<person name="Depienne C."/>
<person name="Dulac O."/>
<person name="Steschenko D."/>
<person name="Leguern E."/>
<person name="Sanz P."/>
<person name="Baulac S."/>
</authorList>
<dbReference type="PubMed" id="21505799"/>
<dbReference type="DOI" id="10.1007/s00109-011-0758-y"/>
</citation>
<scope>VARIANTS EPM2 TYR-46; ALA-69; ASN-146 AND PRO-261</scope>
<scope>CHARACTERIZATION OF VARIANTS EPM2 TYR-46; ALA-69; ASN-146 AND PRO-261</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH EPM2A</scope>
</reference>
<comment type="function">
<text evidence="5 7 8 10 11 13">E3 ubiquitin-protein ligase. Together with the phosphatase EPM2A/laforin, appears to be involved in the clearance of toxic polyglucosan and protein aggregates via multiple pathways. In complex with EPM2A/laforin and HSP70, suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system (UPS). Ubiquitinates the glycogen-targeting protein phosphatase subunits PPP1R3C/PTG and PPP1R3D in a laforin-dependent manner and targets them for proteasome-dependent degradation, thus decreasing glycogen accumulation. Polyubiquitinates EPM2A/laforin and ubiquitinates AGL and targets them for proteasome-dependent degradation. Also promotes proteasome-independent protein degradation through the macroautophagy pathway.</text>
</comment>
<comment type="catalytic activity">
<text>S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="5 7 11 12">Interacts with AGL. Interacts (via the NHL repeats) with EPM2A/laforin. Forms a complex with EPM2A/laforin and HSP70. Interacts with PRDM8 (PubMed:22961547).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6426628"/>
<interactant intactId="EBI-2506661">
<id>O95278</id>
<label>EPM2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6426628"/>
<interactant intactId="EBI-1040928">
<id>Q9WUA5</id>
<label>Epm2a</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Endoplasmic reticulum</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Localizes at the endoplasmic reticulum and, to a lesser extent, in the nucleus.</text>
</comment>
<comment type="tissue specificity">
<text evidence="2">Expressed in brain, cerebellum, spinal cord, medulla, heart, liver, skeletal muscle and pancreas.</text>
</comment>
<comment type="domain">
<text evidence="5">The RING domain is essential for ubiquitin E3 ligase activity.</text>
</comment>
<comment type="disease" evidence="2 4 5 6 9 11">
<disease id="DI-00954">
<name>Epilepsy, progressive myoclonic 2</name>
<acronym>EPM2</acronym>
<description>An autosomal recessive and severe form of adolescent-onset progressive epilepsy. Typically, as seizures increase in frequency, cognitive function declines towards dementia, and affected individuals die usually within 10 years after onset. EPM2 occurs worldwide, but it is particularly common in the mediterranean countries of southern Europe and northern Africa, in southern India and in the Middle East. At the cellular level, it is characterized by accumulation of starch-like polyglucosans called Lafora bodies (LBs) that are most abundant in organs with the highest glucose metabolism: brain, heart, liver and skeletal muscle. Among other conditions involving polyglucosans, EPM2 is unique in that the inclusions are in neuronal dendrites but not axons and the forming polyglucosan fibrils are associated with the endoplasmic reticulum.</description>
<dbReference type="MIM" id="254780"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="The Lafora progressive myoclonus epilepsy mutation and polymorphism database">
<link uri="http://projects.tcag.ca/lafora/"/>
</comment>
<dbReference type="EC" id="2.3.2.27"/>
<dbReference type="EMBL" id="AY324850">
<property type="protein sequence ID" value="AAQ19671.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL589723">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC103888">
<property type="protein sequence ID" value="AAI03889.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC103889">
<property type="protein sequence ID" value="AAI03890.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC103890">
<property type="protein sequence ID" value="AAI03891.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BK001510">
<property type="protein sequence ID" value="DAA01954.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4542.1"/>
<dbReference type="RefSeq" id="NP_940988.2">
<property type="nucleotide sequence ID" value="NM_198586.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.348351"/>
<dbReference type="ProteinModelPortal" id="Q6VVB1"/>
<dbReference type="SMR" id="Q6VVB1"/>
<dbReference type="BioGrid" id="132073">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="IntAct" id="Q6VVB1">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="MINT" id="MINT-8374086"/>
<dbReference type="STRING" id="9606.ENSP00000345464"/>
<dbReference type="iPTMnet" id="Q6VVB1"/>
<dbReference type="PhosphoSitePlus" id="Q6VVB1"/>
<dbReference type="BioMuta" id="NHLRC1"/>
<dbReference type="DMDM" id="50400890"/>
<dbReference type="PaxDb" id="Q6VVB1"/>
<dbReference type="PeptideAtlas" id="Q6VVB1"/>
<dbReference type="PRIDE" id="Q6VVB1"/>
<dbReference type="Ensembl" id="ENST00000340650">
<property type="protein sequence ID" value="ENSP00000345464"/>
<property type="gene ID" value="ENSG00000187566"/>
</dbReference>
<dbReference type="GeneID" id="378884"/>
<dbReference type="KEGG" id="hsa:378884"/>
<dbReference type="UCSC" id="uc003ncl.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="378884"/>
<dbReference type="DisGeNET" id="378884"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000187566.4"/>
<dbReference type="GeneCards" id="NHLRC1"/>
<dbReference type="GeneReviews" id="NHLRC1"/>
<dbReference type="HGNC" id="HGNC:21576">
<property type="gene designation" value="NHLRC1"/>
</dbReference>
<dbReference type="HPA" id="HPA066030"/>
<dbReference type="MalaCards" id="NHLRC1"/>
<dbReference type="MIM" id="254780">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="608072">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q6VVB1"/>
<dbReference type="OpenTargets" id="ENSG00000187566"/>
<dbReference type="Orphanet" id="501">
<property type="disease" value="Lafora disease"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134916338"/>
<dbReference type="eggNOG" id="ENOG410ITF2">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZMHC">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00730000111361"/>
<dbReference type="HOGENOM" id="HOG000113780"/>
<dbReference type="HOVERGEN" id="HBG052617"/>
<dbReference type="InParanoid" id="Q6VVB1"/>
<dbReference type="KO" id="K10602"/>
<dbReference type="OMA" id="RFGHRQQ"/>
<dbReference type="OrthoDB" id="EOG091G08MU"/>
<dbReference type="PhylomeDB" id="Q6VVB1"/>
<dbReference type="TreeFam" id="TF331018"/>
<dbReference type="Reactome" id="R-HSA-3322077">
<property type="pathway name" value="Glycogen synthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3785653">
<property type="pathway name" value="Myoclonic epilepsy of Lafora"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="GeneWiki" id="NHLRC1"/>
<dbReference type="GenomeRNAi" id="378884"/>
<dbReference type="PRO" id="PR:Q6VVB1"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000187566"/>
<dbReference type="CleanEx" id="HS_NHLRC1"/>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006914">
<property type="term" value="P:autophagy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005978">
<property type="term" value="P:glycogen biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031398">
<property type="term" value="P:positive regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.120.10.30">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011042">
<property type="entry name" value="6-blade_b-propeller_TolB-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR013017">
<property type="entry name" value="NHL_repeat_subgr"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR017907">
<property type="entry name" value="Znf_RING_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF14634">
<property type="entry name" value="zf-RING_5"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51125">
<property type="entry name" value="NHL"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="PROSITE" id="PS00518">
<property type="entry name" value="ZF_RING_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0072">Autophagy</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="E3 ubiquitin-protein ligase NHLRC1" id="PRO_0000055980">
<location>
<begin position="1"/>
<end position="395"/>
</location>
</feature>
<feature type="repeat" description="NHL 1">
<location>
<begin position="113"/>
<end position="157"/>
</location>
</feature>
<feature type="repeat" description="NHL 2">
<location>
<begin position="161"/>
<end position="204"/>
</location>
</feature>
<feature type="repeat" description="NHL 3">
<location>
<begin position="205"/>
<end position="245"/>
</location>
</feature>
<feature type="repeat" description="NHL 4">
<location>
<begin position="248"/>
<end position="300"/>
</location>
</feature>
<feature type="repeat" description="NHL 5">
<location>
<begin position="301"/>
<end position="349"/>
</location>
</feature>
<feature type="repeat" description="NHL 6">
<location>
<begin position="350"/>
<end position="393"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="1">
<location>
<begin position="26"/>
<end position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; does not significantly alters the subcellular location as compared to the wild-type." id="VAR_046387" evidence="9">
<original>S</original>
<variation>R</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; dbSNP:rs28940575." id="VAR_019482" evidence="2">
<original>C</original>
<variation>S</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; dbSNP:rs757759398." id="VAR_019483" evidence="2">
<original>F</original>
<variation>S</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; compound heterozygote with A-69; loss of interaction with EPM2A; increased levels of PPP1R3C and glycogen." id="VAR_070793" evidence="11">
<original>C</original>
<variation>Y</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; dbSNP:rs779507031." id="VAR_046388" evidence="4">
<original>E</original>
<variation>Q</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2." id="VAR_046389" evidence="4">
<original>C</original>
<variation>Y</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; compound heterozygote with Y-46; severely reduced interaction with EPM2A; increased levels of PPP1R3C and glycogen; dbSNP:rs28940576." id="VAR_019484" evidence="2 11">
<original>P</original>
<variation>A</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2." id="VAR_019485" evidence="2">
<original>L</original>
<variation>P</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs10949483." id="VAR_019486" evidence="2 3 6">
<original>P</original>
<variation>L</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; the mutant protein targeted exclusively nucleus as compared to predominantly cytoplasmic and partially nuclear localization of the wild-type protein; dbSNP:rs950907157." id="VAR_046390" evidence="9">
<original>L</original>
<variation>P</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; compound heterozygote with P-261; severely reduced interaction with EPM2A; increased levels of PPP1R3C and glycogen; dbSNP:rs769301934." id="VAR_019487" evidence="2 11">
<original>D</original>
<variation>N</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2." id="VAR_046391" evidence="6">
<original>I</original>
<variation>M</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; dbSNP:rs200595273." id="VAR_046392" evidence="6">
<original>C</original>
<variation>R</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; dbSNP:rs121917876." id="VAR_046393" evidence="4">
<original>I</original>
<variation>N</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2." id="VAR_046394" evidence="6">
<original>W</original>
<variation>R</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2." id="VAR_046395" evidence="4">
<original>D</original>
<variation>A</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2." id="VAR_046396" evidence="6">
<original>D</original>
<variation>N</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2." id="VAR_046397" evidence="6">
<original>R</original>
<variation>K</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; compound heterozygote with N-146; loss of interaction with EPM2A; increased levels of PPP1R3C and glycogen; dbSNP:rs879745047." id="VAR_070794" evidence="11">
<original>L</original>
<variation>P</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2." id="VAR_046398" evidence="4">
<original>P</original>
<variation>H</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; significantly alters the distribution of the protein; a great majority of cells expressing the mutant form formed perinuclear inclusion when compared with the wild-type form." id="VAR_046399" evidence="9">
<original>L</original>
<variation>P</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2." id="VAR_046400" evidence="4">
<location>
<begin position="294"/>
<end position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; loss of interaction with EPM2A; dbSNP:rs757858146." id="VAR_019488" evidence="2 5">
<original>Q</original>
<variation>P</variation>
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In EPM2; dbSNP:rs137852859." id="VAR_046401" evidence="4">
<original>D</original>
<variation>A</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with EP2MA." evidence="5">
<original>E</original>
<variation>K</variation>
<location>
<position position="280"/>
</location>
</feature>
<evidence key="1" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12958597"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15781812"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15930137"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16021330"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17908927"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18070875"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18311786"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19036738"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21505799"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22961547"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23624058"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000305"/>
<sequence length="395" mass="42293" checksum="3E8339D00165FBED" modified="2004-07-19" version="2">
MAAEASESGPALHELMREAEISLLECKVCFEKFGHRQQRRPRNLSCGHVVCLACVAALAH
PRTLALECPFCRRACRGCDTSDCLPVLHLIELLGSALRQSPAAHRAAPSAPGALTCHHTF
GGWGTLVNPTGLALCPKTGRVVVVHDGRRRVKIFDSGGGCAHQFGEKGDAAQDIRYPVDV
TITNDCHVVVTDAGDRSIKVFDFFGQIKLVIGGQFSLPWGVETTPQNGIVVTDAEAGSLH
LLDVDFAEGVLRRTERLQAHLCNPRGVAVSWLTGAIAVLEHPLALGTGVCSTRVKVFSSS
MQLVGQVDTFGLSLYFPSKITASAVTFDHQGNVIVADTSGPAILCLGKPEEFPVPKPMVT
HGLSHPVALTFTKENSLLVLDTASHSIKVYKVDWG
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>